Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability

Policy Tracker organizes records from Congress.gov API and Federal Register API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 31 13 * * * UTC
Coverage: 04/16/2026–08/31/2026
Method: Methodology

Title: Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
Record Date: 07/28/2026
Event Classification: regulatory-event
Age Or Deadline Days: 33.04
Public Significance Score: 66.961